Northwest & Ethical Investments L.P. Boosts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Northwest & Ethical Investments L.P. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.6% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 15,741 shares of the medical equipment provider’s stock after purchasing an additional 5,288 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Intuitive Surgical were worth $7,733,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the company. LRI Investments LLC purchased a new position in shares of Intuitive Surgical in the first quarter worth about $30,000. Cetera Investment Advisers raised its stake in shares of Intuitive Surgical by 190.8% during the first quarter. Cetera Investment Advisers now owns 67,619 shares of the medical equipment provider’s stock worth $26,986,000 after acquiring an additional 44,370 shares in the last quarter. Cetera Advisors LLC lifted its stake in Intuitive Surgical by 152.2% in the first quarter. Cetera Advisors LLC now owns 18,037 shares of the medical equipment provider’s stock worth $7,198,000 after purchasing an additional 10,885 shares during the last quarter. Cetera Advisor Networks LLC lifted its stake in shares of Intuitive Surgical by 1.6% in the 1st quarter. Cetera Advisor Networks LLC now owns 35,853 shares of the medical equipment provider’s stock valued at $14,309,000 after acquiring an additional 568 shares during the last quarter. Finally, Cambridge Trust Co. boosted its stake in shares of Intuitive Surgical by 1,093.8% during the first quarter. Cambridge Trust Co. now owns 764 shares of the medical equipment provider’s stock valued at $305,000 after purchasing an additional 700 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Truist Financial raised their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Finally, Raymond James upped their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $526.06.

Insiders Place Their Bets

In related news, insider Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,727,816.73. The trade was a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,459 shares of company stock valued at $26,080,251. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 0.7 %

NASDAQ ISRG opened at $538.55 on Friday. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $552.00. The stock has a 50-day moving average of $508.91 and a 200 day moving average of $467.29. The stock has a market capitalization of $191.82 billion, a price-to-earnings ratio of 86.58, a PEG ratio of 5.30 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.